Tissue / marrow · DNA + RNA✳
Hematology Profile Plus
DNA and RNA profiling to support the assessment of myeloid and lymphoid neoplasms.
A broader view of blood cancers
Bring mutations and molecular expression into focus together.
RNA insightsFusion transcripts · molecular immunophenotyping
Disease characterizationT- and B-cell clonality · IgHV mutation status
Multiple myelomaGene expression and chromosomal risk markers
- SPECIMEN
- Bone marrow, blood, fresh tissue or FFPE
- ANALYSIS
- DNA + RNA
- GENE COVERAGE
- >300 DNA · >1,600 RNA genes
Explore this test ↗Tissue / marrow · DNA✳
Hematology Profile
DNA profiling for hematologic neoplasms, including MDS and myeloproliferative neoplasms, with UBA1 analysis relevant to VEXAS.
A focused DNA profile
Look across key genes in myeloid and other hematologic diseases.
Myeloid markersJAK2 · CALR · MPL
Disease areasMDS · CMML · MPN
Beyond malignancyUBA1 analysis relevant to VEXAS
- SPECIMEN
- Bone marrow, blood, fresh tissue or FFPE
- ANALYSIS
- DNA
- GENE COVERAGE
- >300 DNA genes
Explore this test ↗Liquid biopsy · cfDNA + cfRNA✳
Liquid Trace® Hematology
Cell-free DNA and RNA profiling for hematologic neoplasms using a liquid biopsy specimen.
Beyond the clonotype
Combine cell-free DNA and RNA to see more of the disease.
RNA insightsFusion transcripts · gene expression
ClonalityT- and B-cell clonality
Additional informationChromosomal abnormalities · monitoring support
- SPECIMEN
- Peripheral blood, plasma or CSF
- ANALYSIS
- cfDNA + cfRNA
- GENE COVERAGE
- >300 DNA · >1,600 RNA genes
Explore this test ↗